Announcements Trials
Browse Landscape

Phase

Phase 3 3

Status

Completed 3Unknown 2Recruiting 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Conditions

Leukemia, Myeloid, Acute 71Precursor Cell Lymphoblastic Leukemia-Lymphoma 64Myelodysplastic Syndromes 62Hodgkin Disease 57Leukemia 56Leukemia, Lymphocytic, Chronic, B-Cell 55Multiple Myeloma 51Lymphoma, Non-Hodgkin 48Lymphoma 44Myeloproliferative Disorders 37Graft vs Host Disease 37Lymphoma, Follicular 36Congenital Abnormalities 36Lymphoma, Large B-Cell, Diffuse 35Leukemia, Myeloid, Accelerated Phase 35Lymphoma, Mantle-Cell 34Lymphoma, B-Cell, Marginal Zone 31Leukemia, Myeloid, Chronic-Phase 31Leukemia, Myelogenous, Chronic, BCR-ABL Positive 29Hematologic Neoplasms 29Burkitt Lymphoma 28Leukemia, Myelomonocytic, Chronic 27Blast Crisis 27Primary Myelofibrosis 26Neoplasms, Plasma Cell 25Lymphoma, Large-Cell, Immunoblastic 25Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 18Waldenstrom Macroglobulinemia 17Lymphoma, T-Cell, Cutaneous 16Anemia, Refractory, with Excess of Blasts 16

Interventions

rozanolixizumab 5zilucoplan 4eculizumab 4Rituximab 4Immunoglobulins, Intravenous 4efgartigimod alfa 3Tacrolimus 3Mycophenolic Acid 3Hizentra 3HBM9161 3Data Collection 2Azathioprine 2tofacitinib 1telitacicept 1ravulizumab 1iscalimab 1gamma-Globulins 1apraclonidine 1Thymectomy 1Telemedicine 1Sugammadex 1Sodium Chloride 1Pyridostigmine Bromide 1Prednisone 1Prednisolone 1Plasmapheresis 1Plasma Exchange 1Neurofeedback 1Neostigmine 1Muscle Stretching Exercises 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Myasthenia Gravis × Tacrolimus × Clear all
NCT01325571 2016-03-09

A Study to Compare the Efficacy and Safety of Tacrolimus Capsules in Patient With Myasthenia Gravis

Astellas Pharma Inc

Phase 3 Completed
83 enrolled

Myasthenia Gravis

NCT00309088 2014-08-25

FK506 Phase 3 Study: a Study for Steroid Non-resistant Myasthenia Gravis (MG) Patients

Astellas Pharma Inc

Phase 3 Completed
80 enrolled

Myasthenia Gravis

NCT00309101 2009-06-03

An Open Study for Steroid Resistant, Non-Thymectomized MG Patients

Astellas Pharma Inc

Phase 3 Completed
11 enrolled

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡